Background The N6-methyladenosine (m6A) plays an important role in epigenetic
modification and tumor progression, but the modulations of m6A in hepatocellular carcinoma …

Purpose To investigate the impact of N6-methyladenosine-(m6A) and neutrophil
extracellular traps-(NETs) related lncRNAs (MNlncRNAs) on the prognosis of hepatocellular …

Recently, N 6-methyladenosine (m6A) RNA methylation in eukaryotic mRNA has become
increasingly obvious in the pathogenesis and prognosis of cancer. Moreover, tumor …

Background N6-methyladenosine (m6A) and 5-methylcytosine (m5C) can modify long non-
coding RNAs (lncRNAs), thereby affecting tumorigenesis and tumor progression. However …

Long non-coding RNAs (lncRNAs) and their N6-methyladenosine (m6A) modifications play
an essential role in tumorigenesis and cancer progression. This study was designed to …

Background. Hepatocellular carcinoma (HCC) is a high mortality malignant tumor with
genetic and phenotypic heterogeneity, making predicting prognosis challenging …

N6-methyladenosine (m6a)-related mRNAs and lncRNAs have been explored for their
functions in several cancers. The present study aimed to identify potential signatures of m6a …

Background Early recurrence is the major cause of poor prognosis in hepatocellular
carcinoma (HCC). Long non-coding RNAs (lncRNAs) are deeply involved in HCC …

The current prognostic long noncoding RNA (lncRNA) signatures for hepatocellular
carcinoma (HCC) are still controversial and need to be optimized by systematic …

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver.
Although the RNA modification N6-methyladenine (m6A) has been reported to be involved …